Naimish Patel
Chief Medical Officer at CRISPR Therapeutics · 5 reported transactions in 1 company · latest trade May 29, 2026
Their record
Across their whole record, 1 purchase can be measured; 1 did better than the S&P 500 over the next 6 months.
Typical move +84.7%, S&P 500 +22.6% over the same days.
Their trades
Sold | May 29, 2026 | May 29, 2026 close $56.18 → Oct 29, 2026 close $54.26. S&P 500 +2.1% over the same days. | ||
Sold | May 29, 2025 | May 29, 2025 close $36.78 → Oct 29, 2026 close $54.26. S&P 500 +30.9% over the same days. | ||
Bought | Apr 3, 2025 | Apr 3, 2025 close $32.66 → Oct 29, 2026 close $54.26. S&P 500 +43.9% over the same days. |
$210.6K
May 29, 2026 close $56.18 → Oct 29, 2026 close $54.26. S&P 500 +2.1% over the same days.
$141.3K
May 29, 2025 close $36.78 → Oct 29, 2026 close $54.26. S&P 500 +30.9% over the same days.
BoughtCRISPR Therapeutics
$49.7K
Apr 3, 2025 close $32.66 → Oct 29, 2026 close $54.26. S&P 500 +43.9% over the same days.